APA (7th ed.) Citation

Sasaki, E., Asanuma, H., Momose, H., Furuhata, K., Mizukami, T., & Hamaguchi, I. (2021). Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Sasaki, Eita, Hideki Asanuma, Haruka Momose, Keiko Furuhata, Takuo Mizukami, and Isao Hamaguchi. Nasal Alum-adjuvanted Vaccine Promotes IL-33 Release from Alveolar Epithelial Cells That Elicits IgA Production via Type 2 Immune Responses. Public Library of Science (PLoS), 2021.

MLA (8th ed.) Citation

Sasaki, Eita, et al. Nasal Alum-adjuvanted Vaccine Promotes IL-33 Release from Alveolar Epithelial Cells That Elicits IgA Production via Type 2 Immune Responses. Public Library of Science (PLoS), 2021.